Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials Sponsored by Nikkei (Canada) Marketing Limited
Total 1 results
Nikkei (Canada) Marketing Limited
Withdrawn
Investigating the Effects of Mikei® Red Reishi Essence EX on the Immune System of Prostate Cancer Patients and Patients With Non-cancerous Conditions of the Prostate
Prostate Cancer
United States
Sponsors and Collaborators
BMI Southend Hospital
Irina Jaeger
Yazan Saleh Rajab Hammad
Colorado Mesa University
Homology Medicines, Inc
Saint Petersburg State Budgetary Healthcare Institution, City Clinical Oncology Dispensary
The Affiliated Third Hospital of Jiangsu University
PT. Daewoong Infion
Vital Signs Solutions Ltd
Sociedad Española de Trasplante
Sinovac Life Sciences Co., Ltd.
CliPSBnC
Xiangcheng Zhang
Vietnam Veterans of America Foundation
Roxane Laboratories
Aivita Biomedical, Inc.
Neil Kleiman, MD
Prostate Cancer UK
Clinique Devron, Dijon
Ardeypharm GmbH
View Full List
Medical Conditions
Colorectal Cancer, Somatic (Diagnosis)
Stage IV Mucoepidermoid Carcinoma of the Oral Cavity
Droopy Eyelid
Solid Malignancy
Rhegmatogenous Retinal Detachments
Respiration; Sleep Disorder
NREM Parasomnia
Elevated IgE Level
Post-Infectious Parkinsonism
Refractory Plasmablastic Lymphoma
Epiphrenic Diverticula
CKD Stage 3/4
B Acute Lymphoblastic Leukemia With t(v;11q23.3); KMT2A Rearranged
Comparison of Images From RDSL Existing Slit Lamp Technology
Agitation in Adolescents and Young Adults With ASD
Breast Cancer (Early Breast Cancer)
Locally Advanced or Metastatic ER+ HER2- Breast Cancer
Newly Diagnosed Secondary or High Risk AML
Post Ablation Syndrome
Low Resting Position of Tongue
View Full List
Drug Interventions
Erlotinib
AK109+AK104
Bleomycin
Physiological saline
Livalo® IR
Experimental: Vitamin D3 100,000 IU
Elafibranor 80mg
Dienogest 2.0 mg Test Drug
PREG 300/500 mg
Bupropion
Ravulizumab
Ranibizumab Injection [Lucentis]
Naltrexone SR 32 mg/Bupropion SR 360 mg /day
0.75% ropivacaine
Piperacillin-Tazobactam
JNJ-63723283
SDR-PEP Rifampicin
5-FU
PEG-rhGH with present preparation (R)
Pre-Exposure Prophylaxis (Females)
View Full List
CROs by country
Contract Research Organizations in Belarus
Contract Research Organizations in Bosnia & Herzegovina
Contract Research Organizations in Burkina Faso
Contract Research Organizations in China
Contract Research Organizations in Czech Republic
Contract Research Organizations in Ecuador
Contract Research Organizations in Indonesia
Contract Research Organizations in Italy
Contract Research Organizations in Japan
Contract Research Organizations in Malaysia
Contract Research Organizations in Morocco
Contract Research Organizations in Panama
Contract Research Organizations in Philippines
CRO list by country
CROs in Russia
Avinex
IPHARMA LLC
SanaClis
SGS
Syneos Health
Smooth Drug Development
Intertek
ACROSS Global
Accell Clinical Research
Fortrea
All CROs in Russia
3